BriaCell Therapeutics Corp. (BCTX) Minority Interest (2023 - 2026)
BriaCell Therapeutics (BCTX) posted Minority Interest of -$649099.0 for Q2 2026, up 7.62% sequentially from -$702631.0 in Q1 2026, and down 36.92% YoY from -$1.0 million in Q2 2025.
BriaCell Therapeutics Corp. (BCTX) Minority Interest (2023 - 2026) Analysis & Trends
BriaCell Therapeutics has reported Minority Interest for 4 years, with the latest figure at -$649099.0 in Q2 2026.
- Quarterly Minority Interest fell 36.92% year-over-year to -$649099.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$649099.0 (down 36.92% YoY) and the FY2025 annual result came in at -$546795.0, down 80.75% from the prior year.
- Minority Interest improved to -$649099.0 in Q2 2026 per BCTX's latest filing, from -$702631.0 in the prior quarter.
- Over five years, Minority Interest peaked at -$205111.0 in Q4 2023 and troughed at -$702631.0 in Q1 2026.
- A 4-year average of -$429616.5 and a median of -$376031.0 in 2025 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2025 and 2026: Minority Interest slumped 90.39% in 2025, then slumped 36.92% in 2026.
- Over 4 years, Minority Interest stood at -$205111.0 in 2023, then plunged by 60.7% to -$329623.0 in 2024, then plunged by 90.39% to -$627558.0 in 2025, then declined by 3.43% to -$649099.0 in 2026.
- According to Business Quant data, Minority Interest over the past three periods registered -$649099.0, -$702631.0, and -$627558.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -649,099.00 |
| Jan 31, 2026 | -702,631.00 |
| Oct 31, 2025 | -627,558.00 |
| Jul 31, 2025 | -546,795.00 |
| Apr 30, 2025 | -474,058.00 |
| Jan 31, 2025 | -376,031.00 |
| Oct 31, 2024 | -329,623.00 |
| Jul 31, 2024 | -302,522.00 |
| Apr 30, 2024 | -267,935.00 |
| Jan 31, 2024 | -244,418.00 |
| Oct 31, 2023 | -205,111.00 |